Abstract
Because of the live viral backbone of live attenuated influenza vaccine (LAIV), questions have arisen regarding infection control precautions and restrictions surrounding its use in healthcare personnel (HCP). This document provides guidance from the Society for Healthcare Epidemiology of America regarding use of LAIV in HCP and the infection control precautions that are recommended with its use in this population.
Original language | English (US) |
---|---|
Pages (from-to) | 981-983 |
Number of pages | 3 |
Journal | Infection control and hospital epidemiology |
Volume | 33 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2012 |
ASJC Scopus subject areas
- Epidemiology
- Microbiology (medical)
- Infectious Diseases